Share your stories of how chronic opioid use changed your life in a positive or negative way. PROMPT is doing this for patients specifically because of the July 25 2012, Physicians for Responsible Opioid Prescribing (PROP) petition to the U.S. Food & Drug Administration (FDA) which requests significant label changes for prescription opioids that could prevent honest non-cancer opioid-requiring patients to live in agony. The full PROP proposal to the FDA is available HERE. Our PROMPT response to that proposal is HERE. Please note the blog policy when submitting comments.
Summary: PROP’s proposal, if approved, would limit opioid therapy to non-cancer patients beyond 12 weeks, a maximum daily dose of oral morphine 100mg (or its equivalent in another opioid narcotic), and the diagnosis must be for severe pain only (compared to current FDA approved labeling of moderate to severe pain). PROMPT believes that many legitimate patients fall outside of these parameters and would suffer as a result!
History & Background: Over the course of many years, numerous pain patients nationwide have contacted me seeking advice on what to do, often in a panicked state because their long-term physician caregiver was relocating or retiring. As you might imagine, it frequently involved opioids. To be clear, some of them probably didn’t belong on opioids, some were on the incorrect opioids, others perhaps were drug-seeking, but many seemed to be legitimate patients that honestly were completely dysfunctional without long term chronic opioids. Some couldn’t receive non-opioid analgesics because of certain chronic medical disorders that made non-opioid analgesics far more dangerous than opioids.
Professionals for Rational Opioid Monitoring & PharmacoTherapy (PROMPT) is a multidisciplinary group comprised of many pain clinicians nationwide. PROMPT members include healthcare providers that have direct patient care responsibilities specific to pain management. PROMPT has serious concerns about the safety of chronic opioid use; we are therefore in favor of mitigating these risks by encouraging careful and reasonable patient monitoring to maximize patient care and public safety. We advocate for clinician education, proactive risk stratification, and appropriate therapeutic monitoring.
We would like you to tell your story here by making a comment on this blog. Please feel free to use an anonymous name (or not) in the spirit of confidentiality, as this site is public. We encourage patients also to comment on the FDA U.S. government site, where they are accepting public commentary. The URL link is: http://www.regulations.gov/#!documentDetail;D=FDA-2012-P-0818-0001.
Also, see related Blog Posts below:
Label Changes for Opioids, For or Against
We Intend to be PROMPT with a Challenge to PROP FDA Letter
Visit our new In the News page with links to updates.
Florida pain patients, please be sure to view Living with Pain: Patients Fight Back in Florida, September 2, 2012.
THE FLOODGATES ARE OPEN! You may comment below…